Pancreatic Neuroendocrine Carcinoma

9 clinical trials · Condition

Record	Firm	Date
Assessment of What Patients and Healthcare Providers Value (NCT04483349)	M.D. Anderson Cancer Center	2020-06-11
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013)	National Cancer Institute (NCI)	2017-01-30
Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas (NCT02595424)	ECOG-ACRIN Cancer Research Group	2015-11-06
Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery (NCT02101918)	National Cancer Institute (NCI)	2014-06-18
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" (NCT01365169)	M.D. Anderson Cancer Center	2011-05-25
Diagnosis of PCL With EUS-FNA and Cross-sectional Imaging - A Report of Accuracy (NCT03884179)	Sahlgrenska University Hospital	2007-02-01
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders (NCT00830557)	Mayo Clinic	2000-10-01

Every clearance here is in the API, with alerts when new ones post.